KDIGO 2021 guidelines on Glomerular diseases KDIGO glomerulonephritis guidelines for 2021 are here. Recently they were reviewed and summarised here and here. Summary provides the quick evidence based guide for the management of glomerulonephritis for practicing nephrologists. Unlike the past version, rituximab(RTX) comes out as almost the ‘blue-eyed boy’ of the 2021 guidelines. Instead of … Continue reading ""
Last month in Nephrology,
KDIGO 2021 guidelines on Glomerular diseases KDIGO glomerulonephritis guidelines for 2021 are here. Recently they were…